SAM-e is a natural compound found in your body. It helps with things like inflammation and liver health. It's sometimes used to treat certain conditions, like joint pain or liver problems.
Every report comes from a Lived member, sent anonymously.
Have you tried SAM-e for Depression?
SAM-e (S-adenosyl-L-methionine, also written SAMe) is a compound the body makes from methionine, an amino acid in protein foods. Cells use it to pass small chemical groups to other molecules, a step involved in making brain chemicals, maintaining cell membranes and supporting the liver. In the United States it is sold as a dietary supplement; in some European countries, including Italy and Germany, a pharmaceutical form called ademetionine is available by prescription. Researchers became interested in SAM-e after finding unusual levels of it in people with depression and liver disease. Today people most often take it for low mood, and sometimes for osteoarthritis joint pain or liver problems. None of these uses is an approved treatment in the US, and SAM-e does not correct a deficiency the way a vitamin supplement does.
Depression is where SAM-e has been studied most, with dozens of trials. Several compared it with older prescription antidepressants such as imipramine (a tricyclic antidepressant) and found similar improvement in symptoms. A 2024 analysis of 23 trials concluded that SAM-e taken alone relieved depressive symptoms more than a placebo pill. The picture is less settled than that sounds: a 2016 Cochrane review judged the evidence low to very low quality, most trials were small and lasted only a few weeks, some used injected rather than oral SAM-e, and results as an add-on to a standard antidepressant have been mixed. It is reasonable to call SAM-e one of the better-studied supplements for mood, but not a proven equal to established treatment. For osteoarthritis of the knee or hip, trials comparing SAM-e with anti-inflammatory pain relievers found similar relief, while placebo-controlled trials showed at most a small difference in pain. A Cochrane review advised against routine use until better trials are done. For liver diseases, including alcohol-related liver disease and itching from cholestasis (slowed bile flow) in pregnancy, some studies show improved liver test results, but a benefit on how people actually fare has not been established. Evidence for fibromyalgia, migraine, Alzheimer's disease and other conditions is too limited to draw conclusions, and a trial for quitting smoking found no benefit.
SAM-e is sold mainly as enteric-coated tablets, which pass through the stomach before dissolving. The molecule is unstable and breaks down with exposure to air and moisture; at least one early trial failed partly because its tablets had degraded. That makes packaging and storage more than a marketing detail: tablets sealed individually in foil and kept dry, as the label directs, are more likely to contain what they claim. Depression trials of oral SAM-e generally used 800 to 1,600 milligrams a day, often split into two doses, and it is absorbed best on an empty stomach, about 30 to 60 minutes before a meal. Lower doses on store labels may not match what was studied. Injected doses from European studies do not translate to oral tablets. SAM-e is also considerably more expensive than generic prescription antidepressants, which matters for anything taken long term. Because the right amount depends on why it is being used, the dose is worth settling with a clinician.
Most people who take SAM-e have no side effects or only mild ones. Nausea is the most common, followed by diarrhea, stomach discomfort and occasionally vomiting. Some people find it activating, with restlessness, anxiety or trouble sleeping. Unlike many antidepressants, it has not been linked to weight gain or sexual side effects. The most important serious effect is a shift into mania or hypomania: an unusually high or irritable mood, much less need for sleep, racing thoughts or uncharacteristically impulsive behavior. This is most likely in people with bipolar disorder but has occasionally been reported in people without a known history. If these changes appear, contact your clinician promptly. Long-term safety is less well documented, since most studies lasted weeks, although one two-year liver study reported no serious side effects.
People with bipolar disorder should take SAM-e only under the supervision of a clinician, because it can trigger mania. Anyone with a history of elevated mood episodes should mention it before starting. SAM-e may add to the effects of other products that raise serotonin, a brain chemical targeted by many antidepressants. This includes prescription antidepressants and supplements such as L-tryptophan and St. John's wort. Serious problems appear to be rare, but a case of serotonin syndrome (a reaction caused by too much serotonin activity) has been reported when an antidepressant dose was raised while a person was taking SAM-e, so combining them is a decision to make with a prescriber. SAM-e may also reduce the effect of levodopa, a mainstay treatment for Parkinson's disease. Its safety in pregnancy and breastfeeding has not been established, and there is a theoretical concern for people with weakened immune systems, such as people living with HIV (human immunodeficiency virus). Depression is a treatable medical condition, and SAM-e should not be used to delay an evaluation or replace treatment that is working. If you are already on an antidepressant, do not stop it or switch to SAM-e without talking to your prescriber.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking SAM-e, what you've noticed, or ask the community a question.